The adjusted relative rate of events in participants with C-reactive protein ≥ 2 mg/L (vs. C-reactive protein < 2 mg/L) was 30% higher for MACE (adjusted HR 1.30; 95% CI 1.27–1.33), 24% higher for heart failure (HR 1.24; 95% CI 1.20–1.30), and 35% higher for all-cause mortality (HR 1.35; 95% CI 1.31–1.39) (Table 3). The gene discussed is CRP; the disease is heart failure.